926026-35-9

Basic information

• Product Name: tert-butyl {2-[(4-benzyloxy-3-methoxybenzoyl)(2-thienylmethyl)amino]ethyl}carbamate
• Synonyms: tert-butyl {2-[(4-benzyloxy-3-methoxybenzoyl)(2-thienylmethyl)amino]ethyl}carbamate
• CAS NO: 926026-35-9
• Molecular Weight: 496.627
• Mol File: 926026-35-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl {2-[(4-benzyloxy-3-methoxybenzoyl)(2-thienylmethyl)amino]ethyl}carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl {2-[(4-benzyloxy-3-methoxybenzoyl)(2-thienylmethyl)amino]ethyl}carbamate(926026-35-9)
• EPA Substance Registry System: tert-butyl {2-[(4-benzyloxy-3-methoxybenzoyl)(2-thienylmethyl)amino]ethyl}carbamate(926026-35-9)

Safety Data

• Hazardous Substances Data: 926026-35-9(Hazardous Substances Data)

Upstream product

• 1486-52-8 3-methoxy-4-benzyloxybenzoyl chloride 
• 926025-94-7 tert-butyl {2-[(2-thienylmethyl)amino]ethyl}carbamate 

Relevant articles and documents

SUBSTITUTED 4-BENZYLOXY-BENZOIC ACID AMIDE DERIVATIVES

The present invention relates to novel substituted 4-benzyloxy-benzoic acid amide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor overactivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).